2013 Redox Biology Symposium
Redox Signaling: A Potential Therapeutic Target for Human Disease
The Redox Biology Center's 11th Annual Symposium, Redox Signaling: A Potential Therapeutic Target for Human Disease is scheduled for October 11, 2013 at the University of Nebraska-Lincoln Wick Alumni Center.
"Redox Regulation of the Ryanodine Receptor - from molecular mechanism to drug development"
"Treatment of Pancreatic Cancer with Pharmacological Ascorbate"
Joseph J. Cullen, M.D. Professor of Surgery, University of Iowa Carver College of Medicine
|"Mitochondria - NADPH oxidase cross talk in redox signaling and hypertension"|
Sergey I. Dikalov, Ph.D. Associate Professor, Director of Free Radicals in Medicine Core, Department of Medicine, Vanderbilt University Medical Center
"Landscapes of endogenous cysteine proteomes: functional protein regulationby S-nitrosylation"
Harry Ischiropoulos, Ph.D. Professor of Pediatric and Pharmacology; Children's Hospital of Philadelphia Research Institute and University of Pennsylvania
"Nox Inhibitor Discovery & Vascular Disease, a Retrospective"
"Probing the mechanisms of peroxiredoxin function and protein cysteine oxidation in cell signaling"
Leslie Poole, Ph.D. Professor, Department of Biochemistry, and Director, Center for Structural Biology, Wake Forest School of Medicine
"Nanoformulated Superoxide Dismutase: An Alternative Therapeutic Strategy for Hypertension"
Matt Zimmerman, Ph.D. Associate Professor, Depratment of Cellular and Integrative Physiology, University of Nebraska Medical Center
We hope to see you at the 11th Annual Minisymposium. Advance registration is required but free.